Source: Υπουργείο Υγείας (CY) Revision Year: 2013 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
During the first 1–2 weeks, 2.5 mg 3 times in a 24-hours period is recommended. The dose may then, if necessary, be increased to 5mg 3 times in 24 hours.
Dosage as for adults
The starting dose should normally be 2.5 mg 2 times in 24 hours. However, in some patients, the dose may need to be increased to 2.5 mg 3 times in 24 hours.
Not applicable.
Not applicable.
The tablet should be swallowed whole with a little fluid on an empty stomach. The duration of treatment is determined by the doctor. Dosage should be individualized.
Symptoms: Headache, anxiety, tremor, nausea, tonic muscle cramps, palpitations, tachycardia, arrhythmia. A fall in blood pressure sometimes occurs.
Laboratory findings: Hyperglycaemia and lactacidosis sometime occur. β2-agonists may cause hypokalemia as a result of re-distribution of potassium, but this requires usually no treatment.
Treatment: Mild and Moderate Cases: Reduce the dose. Then increase the dose more slowly if the bronchospasmolytic effect is insufficient.
Severe cases: gastric lavage, administration of activated charcoal. Determine the acid-base balance, blood glucose and electrolytes. Monitor heart rate and rhythm and blood pressure. Metabolic changes should be corrected. A cardio-selective β-blocker (e.g. metoprolol) is recommended for the treatment of arrhythmias causing a hemodynamic deterioration. Beta-blockers should be used with care because of the possibility of inducing inducing bronchial obstruction (bronchoconstricion). If the β2-mediated reduction in peripheral vascular resistance significantly contributes to the fall in blood pressure, a volume expander should be given.
30 months.
Store below 25°C, in the original package, in order to protect from moisture and light.
PVC-Al blisters packed in cartons with 20, 50, 100 tablets and hospital packs of 500 and 1000 tablets.
Not all pack sizes may be marketed.
No special requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
